Synthetic-Bio Foundries
Discover companies that are programming living cells to create the materials of tomorrow. These carefully selected stocks represent pioneers in replacing petrochemical processes with cleaner, more efficient biological alternatives - essentially turning microbes into tiny manufacturing plants.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
Synthetic biology represents a manufacturing revolution where engineered microorganisms replace industrial chemistry. These companies are creating cellular factories that can produce everything from fragrances to fuels more sustainably. This group captures both the foundry platforms and the essential tools enabling this bio-industrial transformation.
What You Need to Know
This collection spans diverse sectors including gene editing, DNA synthesis, enzyme development, and biofuel production. Consider it a high-growth satellite position that offers exposure to the convergence of biology, technology and manufacturing. The integration of AI is accelerating development timelines across the entire sector.
Why These Stocks
We've selected companies with scalable technology platforms, strong intellectual property, and clear commercialization paths. Our picks include both the "foundries" themselves and the "picks and shovels" companies that provide essential tools like DNA synthesis and sequencing technology that make this new form of manufacturing possible.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+136.51%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 136.51% over the next year.
Stocks Rated Buy by Analysts
10 of 14 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Biology's Industrial Revolution
These companies aren't just creating products - they're reinventing how things are made. By programming cells instead of chemicals, they're pioneering manufacturing methods that could make traditional factories obsolete.
AI Is Supercharging Development
Artificial intelligence is dramatically accelerating what these bio-foundries can achieve. Companies integrating AI into their platforms are compressing years of research into months, potentially leapfrogging competitors.
The Sustainable Manufacturing Shift
As corporations face pressure to reduce environmental impact, these bio-alternatives are becoming increasingly attractive. These stocks represent the companies building cleaner production methods that major industries will need to adopt.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Uncle Sam's Semiconductor Stake
The U.S. government is considering an equity stake in Intel to boost domestic semiconductor manufacturing. This strategic move could create a ripple effect, benefiting other American companies involved in the chip-making industry.
The Cybersecurity Consolidation Wave
Accenture's record-breaking acquisition of CyberCX signals a major consolidation trend in the cybersecurity sector. This move highlights the growing demand for AI-powered security solutions, creating potential opportunities for other specialized cybersecurity firms to benefit from increased investment and M&A activity.
American Chipmakers: A Tariff-Driven Shift
President Trump has threatened to impose tariffs of up to 300% on semiconductors to boost domestic production. This creates a potential investment opportunity in U.S.-based semiconductor companies that stand to gain from a shift toward onshore manufacturing.
Frequently Asked Questions
Everything you need to know about the product and billing.